相关实验视频
Updated: Jul 24, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
在血动力学不稳定的肺栓塞患者中基于时间的再注血:早期再注血疗法是否能改善存活率?
Marco Zuin1, Gregory Piazza2, Stefano Barco3,4
1Department of Translational Medicine, University of Ferrara, Azienda Ospedaliero-Universitaria S. Anna, Via Aldo Moro, 8, Ferrara, 44100, Italy.
European heart journal. Acute cardiovascular care
|July 8, 2023
概括
系统性血栓溶解在高风险的肺栓塞 (PE) 中使用不足,尽管有证据支持其益处. 需要进一步的研究来确定在血液动力不稳定的PE患者中再注射治疗的最佳时间.
科学领域:
- 心脏病学 心脏病学
- 肺部医学 肺部医学
- 紧急医疗 紧急医疗
背景情况:
- 高风险肺栓塞 (PE) 具有显著的发病率和死亡率风险.
- 系统性血栓溶解是血液动力学不稳定的PE的主要基于证据的治疗方法,但未得到充分利用.
- 与其他急性心血管事件不同,PE中再注射治疗的最佳时间仍未确定.
研究的目的:
- 对血液动力学不稳定的PE早期再注射治疗的益处进行现有证据的审查.
- 探索优化高风险PE中转注时间的潜在策略.
主要方法:
- 对高风险PE的再输疗法现有证据的文献综述.
- 对治疗指南和临床实践模式的分析.
- 讨论新兴的再注射技术 (导管式血栓溶解,血栓切除术).
主要成果:
- 系统性血栓溶解在临床实践中未得到充分利用,尽管它已被证明是有效的.
- 缺乏对再输血治疗的定义时间窗口,阻碍了及时的干预.
- 早期再注血可能在血液动力学不稳定的PE中提供显著的益处.
结论:
- 早些时候给予再注射疗法需要对高风险PE进行进一步的研究.
- 确定最佳的再输注策略对于改善血液动力不稳定的PE患者的治疗结果至关重要.
- 进一步的研究应侧重于建立明确的治疗时间表和方案.
相关概念视频
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
13
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
13
Pulmonary Embolism III: Nursing Management
15
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15
Pulmonary Embolism I: Introduction
9
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
9
Cardiopulmonary Resuscitation IV: Pharmacological Management
28
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
28
Flail Chest-II
210
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
210
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12

